Latest Articles

Publication Date
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - Business Wire

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen Business Wire

Published: Oct. 18, 2025, 10 a.m.
Multidisciplinary Management of Intracardiac Tumor Thrombus in Low-Grade Endometrial Stromal Sarcoma: Case Report and Literature Review - Frontiers

Multidisciplinary Management of Intracardiac Tumor Thrombus in Low-Grade Endometrial Stromal Sarcoma: Case Report and Literature Review Frontiers

Published: Oct. 15, 2025, 9:11 a.m.
Bindi Irwin Shares Update on ‘Enormous Milestone’ for Disease She Suffers From - SKJ Bollywood News

Bindi Irwin Shares Update on ‘Enormous Milestone’ for Disease She Suffers From SKJ Bollywood News

Published: Oct. 15, 2025, 6:50 a.m.
Fertility Preservation Challenges in Endometrioid Cancer Cases - Bioengineer.org

Fertility Preservation Challenges in Endometrioid Cancer Cases Bioengineer.org

Published: Oct. 14, 2025, 5:59 p.m.
Fertility Preservation Challenges in Endometrioid Cancer Cases - BIOENGINEER.ORG

Fertility Preservation Challenges in Endometrioid Cancer Cases BIOENGINEER.ORG

Published: Oct. 14, 2025, 5:59 p.m.
Fertility Preservation Challenges in Endometrioid Cancer Cases - bioengineer.org

Fertility Preservation Challenges in Endometrioid Cancer Cases bioengineer.org

Published: Oct. 14, 2025, 5:59 p.m.
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials BMC Cancer

Published: Oct. 14, 2025, 2:41 p.m.
‘Invisible diseases’ burden both body and mind. Can therapy help? - Psyche

‘Invisible diseases’ burden both body and mind. Can therapy help? Psyche

Published: Oct. 14, 2025, 10 a.m.
Exploring the Mechanism of Zishen Quyu Jiedu Formula in Treating Endometriosis Based on Network Pharmacology and Experimental Verification - Frontiers

Exploring the Mechanism of Zishen Quyu Jiedu Formula in Treating Endometriosis Based on Network Pharmacology and Experimental Verification Frontiers

Published: Oct. 14, 2025, 8:51 a.m.
Immunohistochemical Evaluation of Phosphatase and Tensin Homolog (PTEN) Expression in Endometrial Lesions: A Cross-Sectional Study in a Tertiary Care Center in South India - Cureus

Immunohistochemical Evaluation of Phosphatase and Tensin Homolog (PTEN) Expression in Endometrial Lesions: A Cross-Sectional Study in a Tertiary Care Center in South India Cureus

Published: Oct. 14, 2025, 6:11 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!